Research / PLAG / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-22-016419 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
1.01% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 13th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.69% · OPTIONAL · VALID
Operating cash generation 64th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.38% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
937.92% · CORE · VALID
Inventory pressure 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
20.70% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
10.18% · CORE · VALID
Operating margin 82th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-16.51% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.14% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.07% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Sep 30, 2022 5/7 normalized Level 3 Dec 31, 2021 6/9 normalized Amended as filed Dec 31, 2021 6/9 normalized Amended as filed Dec 31, 2022 5/7 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Amended as filed Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2023 8/8 normalized Amended as filed Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 4.27%
Current 1.01%
Delta -3.27% Cash Generation Increased
Previous -49.12%
Current -1.38%
Delta 47.74% Growth Increased
Previous 604.54%
Current 937.92%
Delta 333.38% Inventory Pressure Decreased
Previous 93.01%
Current 20.70%
Delta -72.31% Margin Decreased
Previous 15.92%
Current 10.18%
Delta -5.74% Profitability Increased
Previous -27.57%
Current -16.51%
Delta 11.06% R And D Intensity Increased
Previous 0.15%
Current 2.14%
Delta 1.99% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.